Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
, 12, 27

Impact of Clinical Pathway on Clinical Outcomes in the Management of COPD Exacerbation

Comparative Study

Impact of Clinical Pathway on Clinical Outcomes in the Management of COPD Exacerbation

Andrea Ban et al. BMC Pulm Med.


Background: Exacerbations, a leading cause of hospitalization in patients with chronic obstructive pulmonary disease (COPD), affect the quality of life and prognosis. Treatment recommendations as provided in the evidence-based guidelines are not consistently followed, partly due to absence of simplified task-oriented approach to care. In this study, we describe the development and implementation of a clinical pathway (CP) and evaluate its effectiveness in the management of COPD exacerbation.

Methods: We developed a CP and evaluated its effectiveness in a non-randomized prospective study with historical controls on patients admitted for exacerbation of COPD to Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Consecutive patients who were admitted between June 2009 and December 2010 were prospectively recruited into the CP group. Non-CP historical controls were obtained from case records of patients admitted between January 2008 and January 2009. Clinical outcomes were evaluated by comparing the length of stay (LOS), complication rates, readmissions, and mortality rates.

Results: Ninety-five patients were recruited in the CP group and 98 patients were included in the non-CP historical group. Both groups were comparable with no significant differences in age, sex and severity of COPD (p = 0.641). For clinical outcome measures, patients in the CP group had shorter length of stay than the non-CP group (median (IQR): 5 (4-7) days versus 7 (7-9) days, p < 0.001) and 24.1% less complications (14.7% versus 38.8%, p < 0.001). We did not find any significant differences in readmission and mortality rates.

Conclusion: The implementation of CP -reduced the length of stay and complication rates of patients hospitalized for acute exacerbation of COPD.

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles


    1. Ministry of Health Malaysia, Academy of Medicine of Malaysia, Malaysian Thoracic Society. Clinical Practice Guidelines. 2. 2009. Management of Chronic Obstructive Pulmonary disease. MOH/P/PAK/197.09(GU)
    1. Gold PM. The 2007 GOLD Guidelines: a comprehensive care framework. Respir Care. 2009;54(8):1040–1049. - PubMed
    1. Mortaz E, Lazar Z, Koenderman L. et al. Cigarette smoke attenuates the production of cytokines by human plasmacytoid dendritic cells and enhances the release of IL-8 in response to TLR-9 stimulation. Respir Res. 2009;10:47. doi: 10.1186/1465-9921-10-47. - DOI - PMC - PubMed
    1. Gunen H, Hacievliyagil SS, Kosar F. et al. Factors affecting survival of hospitalized patients with COPD. Eur Respir J. 2005;26(2):234–241. doi: 10.1183/09031936.05.00024804. - DOI - PubMed
    1. Lindenauer PK, Pekow P, Gao S. et al. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894–903. - PubMed

Publication types